Although the number of survivors is impressive, survivorship also brings challenges, as many cancer survivors experience long-term physical and psychosocial effects of the disease and its treatment.

In closing, the panel explores the management of side effects experienced by patients during the treatment colorectal cancer. To address this topic, moderator, John L. Marshall, MD, asks each panelist to provide their unique perspective on the optimal management of a variety of adverse events.

The diagnosis of end-stage cancer rarely led to the clinically indicated discontinuation of statin therapy when prescribed for primary prevention.